Taysha Gene Therapies, Inc.
TSHA$3.73+5.67% 1D
$3.6952-week range$7.30
Updated . Prices are snapshots and may be delayed.
Taysha Gene Therapies, Inc. price chart
−17.57% over 7D
$4.53
$3.51
Oct 19
Oct 21
AI Outlook for Taysha Gene Therapies, Inc.
Bearish posture- Long-term trend-30.7% vs 200-day average
- Medium-term trend-29.8% vs 50-day average
- Averages50-day below 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Taysha Gene Therapies, Inc. performance
1D
+5.7%
7D
−15.8%
30D
−26.3%
90D
−37.4%
1Y
−21.0%
About Taysha Gene Therapies, Inc.
Taysha Gene Therapies, Inc. is a biotechnology company based in the United States, listed on NASDAQ since 2020 (ticker TSHA).
Taysha Gene Therapies, Inc. market data
What is the price of Taysha Gene Therapies, Inc. today?
Taysha Gene Therapies, Inc. (TSHA) is at $3.73, +5.67% on the day.
What is the 52-week range of Taysha Gene Therapies, Inc.?
Over the past year Taysha Gene Therapies, Inc. has traded between $3.69 and $7.30. It is currently 1% of the way up that range.
Similar stocks
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
$4.16+14.0%
ESLA
Estrella Immunopharma Inc
$0.5352+72.6%
DRMA
Dermata Therapeutics, Inc. Common Stock
$0.91+18.4%
HUMA
Humacyte, Inc.
$0.4395+20.2%
IBRX
ImmunityBio, Inc.
$10.00−2.0%
SNTI
Senti Biosciences Holdings, Inc.
$0.2615+9.0%
MRNA
Moderna, Inc.
$236.50+4.9%
VSTM
Verastem, Inc.
$9.23+14.8%
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.